MAIA

MAIA Biotechnology, Inc.

Price Chart

Latest Quote

$1.31

-0.02 (-1.50%)

Current Price

Previous Close	$1.33
Open	$1.33
Day High	$1.33
Day Low	$1.29
Volume	258,488

Fetched: 2026-09-01T00:27:52

Stock Information

Shares Outstanding	60.83M
Cash Equivalents	$27.60M
Net Income	$-26.85M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$79.69M
EPS (TTM)	$-0.62
Exchange	ASE

🌐 Visit Website

Recent Price History

Date	Close	Volume
2026-09-01	$1.31	182,277
2026-08-31	$1.31	258,500
2026-08-28	$1.33	361,300
2026-08-27	$1.38	263,000
2026-08-26	$1.39	556,600
2026-08-25	$1.41	938,000
2026-08-24	$1.35	228,000
2026-08-21	$1.39	379,800
2026-08-20	$1.38	223,300
2026-08-19	$1.39	337,000
2026-08-18	$1.37	235,800
2026-08-17	$1.39	266,800
2026-08-14	$1.40	568,800
2026-08-13	$1.34	179,100
2026-08-12	$1.38	179,600
2026-08-11	$1.38	276,300
2026-08-10	$1.41	202,800
2026-08-07	$1.42	333,300
2026-08-06	$1.42	347,400
2026-08-05	$1.40	276,100
2026-08-04	$1.36	384,200
2026-08-03	$1.32	649,800

About MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

📰 Latest News

No news articles available at the moment. Check back later for updates on MAIA.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Interest Expense	$0	$57	$6,863	$6,967
Total Expenses	$23,908,336	$16,877,256	$20,005,662	$15,862,576
Other Income Expense	$1,198,210	$-6,695,710	$205,130	$98,394
Net Non Operating Interest Income Expense	$313,954	$318,310	$27,627	$-5,097
Interest Expense Non Operating	$0	$57	$6,863	$6,967
Operating Expense	$23,908,336	$16,877,256	$20,005,662	$15,862,576
Other Operating Expenses	$-361,350	$-79,954	$-176,719	$785,735
General And Administrative Expense	$9,722,354	$6,947,981	$9,070,124	$6,143,527
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-22,396,172	$-23,254,656	$-19,772,905	$-15,769,279
Net Interest Income	$313,954	$318,310	$27,627	$-5,097
Interest Income	$313,954	$318,367	$34,490	$1,870
Normalized Income	$-23,594,382	$-16,558,946	$-19,978,035	$-15,867,673
Net Income From Continuing And Discontinued Operation	$-22,396,172	$-23,254,656	$-19,772,905	$-15,769,279
Total Operating Income As Reported	$-24,269,686	$-16,957,210	$-20,182,381	$-16,176,201
Net Income Common Stockholders	$-22,396,172	$-23,254,656	$-19,772,905	$-16,219,857
Net Income	$-22,396,172	$-23,254,656	$-19,772,905	$-15,769,279
Net Income Including Noncontrolling Interests	$-22,396,172	$-23,254,656	$-19,772,905	$-15,769,279
Net Income Continuous Operations	$-22,396,172	$-23,254,656	$-19,772,905	$-15,769,279
Pretax Income	$-22,396,172	$-23,254,656	$-19,772,905	$-15,769,279
Interest Income Non Operating	$313,954	$318,367	$34,490	$1,870
Operating Income	$-23,908,336	$-16,877,256	$-20,005,662	$-15,862,576
Special Income Charges	-	-	-	$0
Per Share
Diluted EPS	$-0.70	$-1.05	$-1.49	$-1.75
Basic EPS	$-0.70	$-1.05	$-1.49	$-1.75
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-23,594,382	$-16,558,889	$-19,971,172	$-15,860,706
Total Unusual Items	$1,198,210	$-6,695,710	$205,130	$98,394
Total Unusual Items Excluding Goodwill	$1,198,210	$-6,695,710	$205,130	$98,394
EBITDA (Bullshit earnings)	$-22,396,172	$-23,254,599	$-19,766,042	$-15,762,312
EBIT	$-22,396,172	$-23,254,599	$-19,766,042	$-15,762,312
Diluted Average Shares	$32,114,608	$22,197,517	$13,261,572	$9,276,761
Basic Average Shares	$32,114,608	$22,197,517	$13,261,572	$9,276,761
Diluted NI Availto Com Stockholders	$-22,396,172	$-23,254,656	$-19,772,905	$-16,219,857
Gain On Sale Of Security	$1,198,210	$-6,695,710	$205,130	$98,394
Research And Development	$14,547,332	$10,009,229	$11,112,257	$8,933,314
Selling General And Administration	$9,722,354	$6,947,981	$9,070,124	$6,143,527
Other Gand A	$9,722,354	$6,947,981	$9,070,124	$6,143,527
Otherunder Preferred Stock Dividend	-	-	$0	$450,578
Minority Interests	-	-	-	$0
Other Special Charges	-	-	-	-

Fetched: 2026-09-01

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$2,375,863	$3,634,636	$477,511	$8,507,793
Total Assets	$9,704,656	$10,155,279	$7,566,852	$12,022,040
Total Non Current Assets	$2,800	$2,800	$2,800	$214,003
Other Non Current Assets	$2,800	$2,800	$2,800	$2,800
Current Assets	$9,701,856	$10,152,479	$7,564,052	$11,808,037
Other Current Assets	$1,043,825	$473,834	$268,677	$554,321
Receivables	$0	$77,347	$144,680	$302,789
Cash Cash Equivalents And Short Term Investments	$8,658,031	$9,601,298	$7,150,695	$10,950,927
Cash And Cash Equivalents	$8,658,031	$9,601,298	$7,150,695	$10,950,927
Cash Financial	$8,658,031	$9,601,298	$7,150,695	$10,950,927
Other Receivables	-	$77,347	$144,680	$302,789
Non Current Deferred Assets	-	-	$0	$211,203
Prepaid Assets	-	-	-	-
Liabilities
Total Liabilities Net Minority Interest	$7,328,793	$6,520,643	$7,089,341	$3,514,247
Total Non Current Liabilities Net Minority Interest	$1,492,395	$2,690,605	$2,152,188	$245,341
Derivative Product Liabilities	$1,492,395	$2,690,605	$2,152,188	$245,341
Current Liabilities	$5,836,398	$3,830,038	$4,937,153	$3,268,906
Payables And Accrued Expenses	$4,636,443	$2,888,940	$3,325,719	$2,174,324
Payables	$2,038,803	$1,512,436	$1,638,546	$1,165,505
Accounts Payable	$2,038,803	$1,512,436	$1,638,546	$1,165,505
Current Deferred Liabilities	-	-	-	$0
Interest Payable	-	-	-	-
Equity
Common Stock Equity	$2,375,863	$3,634,636	$477,511	$8,507,793
Total Equity Gross Minority Interest	$2,375,863	$3,634,636	$477,511	$8,507,793
Stockholders Equity	$2,375,863	$3,634,636	$477,511	$8,507,793
Gains Losses Not Affecting Retained Earnings	$-50,228	$-30,615	$-16,260	$-15,973
Other Equity Adjustments	$-50,228	$-30,615	$-16,260	$-15,973
Retained Earnings	$-109,631,005	$-87,234,833	$-63,980,177	$-44,207,272
Other
Ordinary Shares Number	$38,624,289	$26,157,788	$16,986,254	$10,955,904
Share Issued	$38,624,289	$26,157,788	$16,986,254	$10,955,904
Tangible Book Value	$2,375,863	$3,634,636	$477,511	$8,507,793
Invested Capital	$2,375,863	$3,634,636	$477,511	$8,507,793
Working Capital	$3,865,458	$6,322,441	$2,626,899	$8,539,131
Total Capitalization	$2,375,863	$3,634,636	$477,511	$8,507,793
Additional Paid In Capital	$112,053,233	$90,897,468	$64,472,249	$52,729,942
Capital Stock	$3,863	$2,616	$1,699	$1,096
Common Stock	$3,863	$2,616	$1,699	$1,096
Preferred Stock	$0	$0	$0	$0
Pensionand Other Post Retirement Benefit Plans Current	$1,199,955	$941,098	$1,611,434	$1,094,582
Current Accrued Expenses	$2,597,640	$1,376,504	$1,687,173	$1,008,819
Treasury Shares Number	-	-	$0	-
Minority Interest	-	-	-	-
Dueto Related Parties Current	-	-	-	-

Fetched: 2026-09-01

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-18,844,598	$-15,704,461	$-13,071,016	$-12,096,104
Operating Activities
Operating Cash Flow	$-18,844,598	$-15,704,461	$-13,071,016	$-12,096,104
Cash Flow From Continuing Operating Activities	$-18,844,598	$-15,704,461	$-13,071,016	$-12,096,104
Operating Gains Losses	$-1,198,210	$6,695,710	$-205,130	$-98,394
Financing Activities
Issuance Of Capital Stock	$17,621,258	$18,754,708	$11,416,960	$13,973,560
Financing Cash Flow	$17,906,547	$18,176,609	$9,270,901	$12,477,169
Cash Flow From Continuing Financing Activities	$17,906,547	$18,176,609	$9,270,901	$12,477,169
Net Other Financing Charges	$-617,133	$-795,257	$-2,147,491	$-1,965,791
Net Common Stock Issuance	$17,621,258	$18,754,708	$11,416,960	$13,973,560
Common Stock Issuance	$17,621,258	$18,754,708	$11,416,960	$13,973,560
Other
End Cash Position	$8,658,031	$9,601,298	$7,150,695	$10,950,927
Beginning Cash Position	$9,601,298	$7,150,695	$10,950,927	$10,574,292
Effect Of Exchange Rate Changes	$-5,216	$-21,545	$-117	$-4,430
Changes In Cash	$-938,051	$2,472,148	$-3,800,115	$381,065
Proceeds From Stock Option Exercised	$902,422	$217,158	$1,432	$469,400
Change In Working Capital	$1,499,319	$-1,237,749	$3,086,054	$352,782
Change In Payables And Accrued Expense	$1,998,675	$-1,098,619	$2,641,818	$1,127,088
Change In Accrued Expense	$1,478,955	$-979,792	$2,169,921	$915,742
Change In Payable	$519,720	$-118,827	$471,897	$211,346
Change In Account Payable	$519,720	$-118,827	$471,897	$211,346
Change In Prepaid Assets	$-579,766	$-195,935	$285,831	$-505,233
Change In Receivables	$80,410	$56,805	$158,405	$-269,395
Other Non Cash Items	$618,813	$179,490	$731,661	$1,099,360
Stock Based Compensation	$2,631,652	$1,912,744	$3,089,304	$2,319,427
Gain Loss On Investment Securities	$-1,198,210	$6,695,710	$-205,130	$-98,394
Net Income From Continuing Operations	$-22,396,172	$-23,254,656	$-19,772,905	$-15,769,279
Change In Other Current Assets	-	-	$0	$322
Repayment Of Debt	-	-	-	$0
Issuance Of Debt	-	-	-	$0
Net Issuance Payments Of Debt	-	-	-	$0
Net Long Term Debt Issuance	-	-	-	$0
Long Term Debt Payments	-	-	-	$0
Long Term Debt Issuance	-	-	-	$0
Change In Other Working Capital	-	-	-	$440,379

Fetched: 2026-09-01